Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Gx-G6
DRUG
2 trials
Sponsors
Genexine, Inc.
Conditions
Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 1
Safety and Tolerability of GX-G6 in Healthy Male Subjects
Completed
NCT03651466
Genexine, Inc.
Diabetes Mellitus
Start: 2017-08-31
End: 2018-06-28
Updated: 2018-08-29
Phase 2
A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
NCT03962010
Genexine, Inc.
Type 2 Diabetes Mellitus
Start: 2019-06-01
End: 2022-07-01
Target: 78
Updated: 2019-05-23
Related Papers
114-LB: GX-G6, a Novel Long-Acting Glucagon-Like Peptide Receptor Agonist: Result of Phase I Study in Healthy Volunteers
Diabetes
2019-06-01
1 citations